VD/VDR-vd-vdr.com

4-[(Hexylcarbamoyl)Amino]-N-[4-(2-{[(2S)-2-Hydroxy-3-(4-Hydroxyphenoxy)Propyl]Amino}Ethyl)Phenyl]Benzenesulfonamide

June 21, 2017

prudect name : 4-[(Hexylcarbamoyl)Amino]-N-[4-(2-{[(2S)-2-Hydroxy-3-(4-Hydroxyphenoxy)Propyl]Amino}Ethyl)Phenyl]BenzenesulfonamideL755507 Synonyms: CAS NO: 159182-43-1Molecular Formula: C30H40N4O6SMolecular Weight: 584.73Purity: 98% minSolubility: In DMSOStorage: -20 oC web site: www.medchemexpress.com References PubMed ID：:http://www.ncbi.nlm.nih.gov/pubmed/18524877

📌

0💬 read more

Lesinurad sodium (RDEA594 sodium) is an once-daily inhibitor of URAT1; URAT1 is a transporter in the kidney that regulates uric acid excretion from the body.

prudect name : Lesinurad sodium (RDEA594 sodium) is an once-daily inhibitor of URAT1; URAT1 is a transporter in the kidney that regulates uric acid excretion from the body.Lesinurad(RDEA594) sodium Synonyms:…

📌

0💬 read more

Lenalidomide (Revlimid) is a derivative of thalidomide with antiangiogenic and antineoplastic properties(cell IC50= 10 ¦ÌM). [1] It was initially intended as a treatment for multiple myeloma.Lenalidomide inhibits TNF-alpha production, stimulates T cells, reduces serum levels of the cytokines vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), and inhibits angiogenesis. This agent also promotes G1 cell cycle arrest and apoptosis of malignant cells.

prudect name : Lenalidomide (Revlimid) is a derivative of thalidomide with antiangiogenic and antineoplastic properties(cell IC50= 10 ¦ÌM). [1] It was initially intended as a treatment for multiple myeloma.Lenalidomide inhibits…

📌

0💬 read more

LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases.

prudect name : LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases.LY2183240 Synonyms: CAS NO: 874902-19-9Molecular Formula: C17H17N5OMolecular Weight: 307.35Purity: 98% minSolubility: In DMSOStorage: −20°C web…

📌

0💬 read more

Lapatinib (GW572016) is a selective inhibitor of both epidermal growth factor receptor (EGFR) and HER-2 tyrosine kinases.

prudect name : Lapatinib (GW572016) is a selective inhibitor of both epidermal growth factor receptor (EGFR) and HER-2 tyrosine kinases.Lapatinib ditosylate Synonyms: GW-572016CAS NO: 388082-78-8Molecular Formula: C29H26ClFN4O4S.2(C7H8O3S)Molecular Weight: 925.46Purity: 99%Solubility:…

📌

0💬 read more

Lornoxicam non-steroidal anti-inflammatory analgesic drugs, the Department of thiazide derivatives

prudect name : Lornoxicam non-steroidal anti-inflammatory analgesic drugs, the Department of thiazide derivativesLornoxicam Synonyms: CAS NO: 70374-39-9Molecular Formula: C13H10ClN3O4S2Molecular Weight: 371.82Purity: ≥99%Solubility: Storage: −20°C 2 years web site: www.medchemexpress.com References…

📌

0💬 read more

prudect name : LonafarnibSynonyms: Sch-66336, SarasarCAS NO: 193275-84-2Molecular Formula: C27H31Br2ClN4O2Molecular Weight: 638.82Purity: 98% minSolubility: Storage:

prudect name : Lonafarnib Synonyms: Sch-66336, SarasarCAS NO: 193275-84-2Molecular Formula: C27H31Br2ClN4O2Molecular Weight: 638.82Purity: 98% minSolubility: Storage: -20°C web site: www.medchemexpress.com References PubMed ID：:http://www.ncbi.nlm.nih.gov/pubmed/18524756

📌

0💬 read more

LY2409881 trihydrochloride is a novel selective inhibitor of IKK2 with IC50 of 30 nM; IC50 for IKK1 and other common kinases is at least one log higher.

prudect name : LY2409881 trihydrochloride is a novel selective inhibitor of IKK2 with IC50 of 30 nM; IC50 for IKK1 and other common kinases is at least one log higher.LY2409881…

📌

0💬 read more

LRRK2-IN-1 is a cell-permeable, ATP competitive, potent, and selective LRRK2 inhibitor. (IC50 of 13 nM, 6 nM, and 2.45 ¦ÌM for wild type, G2019S mutant, and drug resistant A2016T mutant LRRK2, respectively, in an in vitro ATP-site competititon binding assay). LRRK2-IN-1 is useful in treatment of Parkinson¡¯s disease.

prudect name : LRRK2-IN-1 is a cell-permeable, ATP competitive, potent, and selective LRRK2 inhibitor. (IC50 of 13 nM, 6 nM, and 2.45 ¦ÌM for wild type, G2019S mutant, and drug…

📌

0💬 read more

LY-2584702 is an orally available inhibitor of p70S6K signaling; inhibits p70S6K and prevents phosphorylation of the S6 subunit of ribosomes.

prudect name : LY-2584702 is an orally available inhibitor of p70S6K signaling; inhibits p70S6K and prevents phosphorylation of the S6 subunit of ribosomes.LY-2584702;LY2584702 Synonyms: CAS NO: 1082949-67-4Molecular Formula: C21H19F4N7Molecular Weight:…

📌

0💬 read more